MT-1 (afamelanotide): Selective for MC1R (melanin production receptor) 13-residue linear peptide FDA-approved for EPP Side effects: typically headache, fatigue, nausea generally mild More expensive per dose, more conservative tanning MT-2: Activates MC1R, MC3R, MC4R, MC5R broader receptor profile 7-residue cyclic peptide (smaller) Not FDA-approved Side effects: nausea, flushing, libido effects (MC4R activation), potential melanoma concerns with new moles Cheaper per dose, faster/darker tanning For tanning users prioritizing safety profile and tolerability, MT-1 is the more documented option despite higher per-mg cost
The particle stack of semaglutide and taspoglutide-GLP-1R-Gs complexes from RELION consensus refinement were imported into the cryoSPARC environment
Storage Conditions: Store in a cool, dry, and dark place away from direct heat, light, and moisture
Dulaglutide Dulaglutide (Trulicity) is administered subcutaneously at a maximum dose of 1.5 mg once weekly, and available on license since 2014 for people with T2D as monotherapy in those who cannot take metformin or as add-on treatment in people using oral agents and/or insulin
Pricing Disclaimer: All pricing, subscription terms, promotional offers, and refund policies described were based on information published on the official SkinnyRx website at the time of publication (April 2026) and are subject to change